Recent Articles from GlobeNewswire

VALLOUREC WINS A CONTRACT FOR THE PRINOS CO2 CARBON STORAGE PROJECT IN GREECE

SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced the closing of its previously announced public offering of an aggregate 4,322,489 Class A Ordinary Shares (“the Offering”) at a price of $1.15 per share (“the Offering Price”) to the public, for a total of approximately $4.97 million of gross proceeds to the Company, before deducting underwriting discounts and offering expenses.

Mount Laurel Township, NJ, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Leader’s Advantage Acquisition Corp. (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today that it has priced its initial public offering of 15,000,000 units at $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, September 18, 2026, under the ticker symbol “LEDRU." Each whole warrant is exercisable to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq under the symbols “LEDR” and “LEDRW,” respectively. The offering is expected to close on September 21, 2026, subject to customary closing conditions.

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer, today announced the pricing of its upsized initial public offering of 23,333,334 shares of common stock at a price to the public of $15.00 per share. The gross proceeds to Electra from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Electra, are expected to be approximately $350.0 million. In addition, Electra has granted the underwriters a 30-day option to purchase up to an additional 3,500,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being offered by Electra.

La Chaux-de-Fonds, CH, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Black Sterling, a Swiss growth operator formed from Black Flower Creative House and Nexaia, has introduced an integrated growth model that brings strategy, creative production, custom technology, AI, and automation together to help SMEs turn commercial priorities into coordinated execution.

MELBOURNE, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Orion180 Insurance Group Inc. ("Orion180"), a leading provider of flexible, customer-centric homeowners and flood insurance solutions, today announced the pricing of its initial public offering of 20,000,000 shares of its Class A common stock, at an initial public offering price of $12.00 per share. In addition, Orion180 has granted the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on September 18, 2026, under the ticker symbol "OIG." The offering is expected to close on September 21, 2026, subject to customary closing conditions.

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) between February 12, 2026 and August 5, 2026, inclusive.What To Do Next:

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) between August 8, 2024 and May 13, 2026, inclusive.What To Do Next:

WESTCHESTER, Ill., Sept. 17, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.83 per share on the Company’s common stock. The dividend is payable on Oct. 20, 2026, to stockholders of record at the close of business on Oct. 1, 2026. This is the twelfth consecutive year Ingredion’s board has approved a quarterly dividend increase in the third quarter.

The company’s new name, shared with its Karman platform, reflects a mission that started on the grid and now takes on the biggest demand straining it

PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced the presentation of the results from three clinical studies at the American Orthopaedic Foot & Ankle Society (“AOFAS”) Annual Meeting in Seattle, Washington. The presentations include data on the milestone 5-year ALIGN3D® Lapiplasty®, the MTA3D® Adductoplasty® and the SPRINT™ SpeedPlate® clinical studies.

LOUISVILLE, Ky., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by AstraZeneca for Etcamah™ (camizestrant), which is indicated for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (FDA)-authorized test.1

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Innventure (INV) To Contact Him Directly To Discuss Their Options

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Flotek Industries, Inc. (NYSE: FTK) (“Flotek” or the “Company”) for potential violations of the federal securities laws.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Taboola.com (TBLA) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In GoDaddy (GDDY) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hyliion (HYLN) To Contact Him Directly To Discuss Their Options

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Ensign Group (NASDAQ: ENSG) (“Ensign” or the “Company”) for potential violations of the federal securities laws.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aevex (AVEX) To Contact Him Directly To Discuss Their Options

Maganti IT Resources, LLC Publishes New Industry Analysis on Maritime Digitalization, Highlighting the Shift From Data Collection to Connected Systems and Trusted Operational Intelligence

CAMBRIDGE, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the publication of results from a prespecified adolescent subgroup analysis of the Phase 3 VALIANT study evaluating EMPAVELI® (pegcetacoplan) in the Clinical Journal of the American Society of Nephrology (CJASN). The dedicated subgroup analysis was first presented at the 2025 Annual Meeting of the European Society of Paediatric Nephrology (ESPN).

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating EquipmentShare.com Inc. (NASDAQ: EQPT) (“EquipmentShare” or the “Company”) for potential violations of the federal securities laws.

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Cardinal Infrastructure Group, Inc. (NASDAQ: CDNL) (“Cardinal” or the “Company”) for potential violations of the federal securities laws.

SAXONBURG, Pa., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: OHR), the global leader in photonics, today announced the expansion of its Pluggable Optical Line System (POLS) portfolio, with the full C-band, high-power variable-gain amplifier optical line system in a compact QSFP form factor. Designed for the latest generation of 800G ZR/ZR+ digital coherent optics, the enhanced POLS supports up to 32 DWDM wavelengths over a single fiber pair, enabling as much as 25.6Tbps of AI datacenter traffic across links from 2km to 200km.

WALTHAM, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 14 newly hired employees. The awards were made as an inducement material to the newly hired employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4).

BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (“Rapid7”) (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, announced that the company granted inducement awards, effective as of September 15, 2026, to employees as a material inducement to commence employment with Rapid7 and its subsidiaries.

Satellite completes next-generation constellation, increasing service capability in key markets

MINNEAPOLIS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”), a leading cannabis company and agricultural markets platform today announced that, in connection with a confidential settlement agreement (the “Settlement Agreement”) with SHWZ Altmore, LLC (“Altmore”) and certain other parties, the Company will issue a total of 462,963 subordinate voting shares of the Company (the “Settlement Shares”) to Altmore and Altmore Debt I, LP as consideration for the Company’s acquisition of certain secured obligations and related liens held by Altmore (the “Assigned Interest”), pursuant to an assignment and assumption agreement entered into in connection with the Settlement Agreement.

IRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the closing of its previously announced underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17.25 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 1,043,484 shares of common stock at a purchase price of $17.2499 per share, which equals the public offering price per share of the common stock less the $0.0001 exercise price per share of each pre-funded warrant. In addition, the underwriters exercised their option in full and purchased 1,304,348 additional shares of common stock. Including the option exercise, the aggregate gross proceeds from this offering were $172.5 million, before deducting underwriting discounts and commissions and offering expenses payable by Beta Bionics.

September 17, 2026 – 22:01PM CET

VANCOUVER, BC and BOSTON, MA, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced it has submitted a New Drug Application (NDA) for azetukalner in focal seizures (FS) to the U.S. Food and Drug Administration (FDA).

DALLAS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced that the U.S. Small Business Administration (the “SBA”) has approved Capital Southwest SBIC II, LP’s (“SBIC II”) request to increase its leverage commitment from $175 million to $250 million pursuant to recent legislation.

ABU DHABI, United Arab Emirates, Sept. 17, 2026 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIP Group” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced that it will hold an extraordinary general meeting of shareholders (the “EGM”) at 8:00 p.m., Hong Kong time, on October 16, 2026 at 29/F, Entertainment Building, 30 Queen's Road Central, Central, Hong Kong.

Power-dense permanent magnet propulsion motors and advanced variable-frequency drives will power the Republic of Korea Navy's first full-electric-drive surface combatant

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- NewHold Investment Corp. III (NASDAQ: NHIC, “NewHold”), a publicly traded special purpose acquisition company, today announced that its shareholders have approved all proposals related to the previously announced business combination (the “Business Combination”) with newcleo plc (“newcleo”), a public limited company incorporated under the laws of England and Wales (f/k/a NewCleo Ltd., a private limited company incorporated under the laws of England and Wales) at NewHold’s Extraordinary General Meeting held today, Thursday, September 17, 2026.

Sets the Record Straight Regarding Misrepresentations Included in Empery Digital’s Recent Communications

FAYUVI is a highly anticipated, first-ever treatment option with the potential to stop or slow the devastating, irreversible neurologic progression and loss of function associated with Sanfilippo syndrome Type A

Company presented IND-enabling preclinical data earlier today at the AAST annual meeting

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

$30 Million Equity Financing and $15 Million Debt Facility Support Continued Commercial Expansion, Innovation and Global Growth

Innovative gene therapy offers a new option for children with a rare, progressive neurodevelopmental disease

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) --

Amid stubbornly high SoCal gas prices, Dodgers fans are encouraged to gear up and drive to Longo Lexus in El Monte to score one of 333 $75 gas gift cards from 76®, available while supplies last

The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com

Caramel Apple ChataCoffee™, Pumpkin Pie Mini Churros and Red & Green Chile Cheesy Enchilada Double Chicken Bowls all available for a limited time

As 3 out of 5 young people worry about AI's impact on their future careers, The DeBruce Foundation finds Career Literacy and strong networks help young people navigate with confidence

First offering outside Colorado gives eligible accredited investors a preferred equity position in a stabilized 297-room hotel Realberry has owned and operated since 2018

Settlement resolves longstanding litigation, clarifies regulatory expectations, and does not require material changes to the Company’s operations

Deal follows recent Rig-A-Lite acquisition, giving Phoenix unmatched industrial lighting portfolio

Building on more than 30 years of learning and experience through Children’s Advocacy Centers of Texas, EverUpward will use Google.org funding to expand EverBright, its flagship child sexual abuse prevention initiative

BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- CDM Smith is pleased to announce our new chief financial officer, Daniel “Dan” Clark. Clark succeeds Thierry Desmaris, who will retire after more than a decade of exceptional service to the firm. As CFO, Clark will lead the firm’s financial strategy, enterprise risk management, and governance stewardship while helping advance CDM Smith’s long-term growth, direct employee ownership culture, and strategic vision. 

“Pure Garnacha Grenache, Pure Europe. Quality Wines from France and Spain.”

HealthEx PowerPlug for Ultrahuman Ring enables members to catch missed follow-ups and see their medical records alongside their biomarkers

Washington, DC, Sept. 17, 2026 (GLOBE NEWSWIRE) -- As diesel fuel prices climb to record highs across the United States, raising costs for freight movement, agriculture, construction, and other essential industries, the Engine Technology Forum (ETF) has released new analysis based on current fuel prices identifying strategies to reduce fuel consumption and provide immediate and long-term relief from this period of higher prices.

New York, NY, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registered broker-dealer and wholly owned subsidiary of Chaince Digital Holdings Inc. (NASDAQ: CD), today announced that it has been engaged as the exclusive sales agent for the at-the-market (“ATM”) equity offering program of Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), a company that specializes in supplying premium-class sturgeon caviar and related products including premium grade wines. The engagement is made pursuant to an At the Market Sales Agreement dated September 8, 2026 (the “Sales Agreement”), under which the Company may offer and sell, from time to time, Class A ordinary shares having an aggregate offering price of up to US$200 million through Chaince.

LAKE FOREST, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Del Taco, the nation’s second-largest Mexican quick service restaurant*, is cranking up the heat with a new lineup featuring Flamin’ Hot® flavored Queso on some of the brand’s most popular menu items. Available for a limited time, the lineup brings together the distinctive heat of CHEETOS® FLAMIN’ HOT® and Del Taco favorites, giving guests new ways to turn up the intensity on their go-to orders.

Special broadcast and exclusive digital capsules spotlight a timely national conversation during Hispanic Heritage Month 

Dual-drive failure protection. Complete data transparency. Up to 26,000MB/s. OWC SoftRAID 9 delivers what hardware RAID simply can't.

Study reports 83.5% improved or held their diagnostic stage in real-world patients with early-stage cognitive impairment and dementia

Staff Sgt. Kenneth Garcia—a U.S. Army Infantryman and Scout Team Leader who stars in the campaign—shares an inside look at “Field Tested” and how his Army training helped him develop confidence, leadership, and resilience

TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- FirstService Corporation (TSX: FSV; NASDAQ: FSV) ("FirstService") announced today that its Board of Directors has declared a quarterly cash dividend on the outstanding Common Shares of US$0.305 per Common Share. The dividend is payable on October 7, 2026 to holders of Common Shares of record at the close of business on September 30, 2026. The dividend on Common Shares is an "eligible dividend" for Canadian income tax purposes.

NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Gordian’s IDIQ solutions now available through Sourcewell contract 091620-GGI to help Arizona agencies accelerate building repairs, renovations and construction projects.

The refreshed hotel introduces redesigned guestrooms, enhanced public spaces, upgraded dining, and new wellness-focused accommodations.

Thoughtfully renovated all-suite hotel offers residential comfort near Mystic and Southern Connecticut’s iconic attractions and major military and defense hubs.

New ticket designs revealed ahead of statewide availability, alongside exclusive VIP Club opportunities

Passengers on United airplanes with Starlink-enabled seatback screens have access to live college and pro football games starting this week across 9 major sports networks

Dayforce positioned highest for Ability to Execute

NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against York Space Systems, Inc. (“York Space Systems” or the “Company”) (NYSE: YSS), if they purchased or otherwise acquired (a) York Space Systems common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2026 initial public offering (“IPO” or the “Offering”); and/or (b) securities between January 29, 2026 and May 11, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Colorado.

NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against Wix.com Ltd. (NasdaqGS: WIX) (“Wix” or the “Company”), if they purchased or otherwise acquired Wix securities between February 19, 2025 and May 12, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois.

$2,500 awards support aspiring physicians and advanced practice providers on their journey from training to practice

NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Simply Good Foods Company (“Simply Good” or the “Company”) (NasdaqCM: SMPL), if they purchased Simply Good shares between October 24, 2024 and April 8, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation (NasdaqGM: PRCT) (“Procept” or the “Company”), if they purchased the Company’s shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Chef, author and TV host joins leading nonprofit to provide connection and support to service members and their families.